Patents by Inventor Yile CHEN

Yile CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132515
    Abstract: The present invention provides a toxin molecule suitable for an antibody drug conjugate. In particular, the present invention provides a compound represented by formula (I) below or a pharmaceutically acceptable salt or hydrate thereof. The compound of the present invention can be used in the preparation of a pharmaceutical composition for treating diseases associated with tumor cell proliferation.
    Type: Application
    Filed: January 28, 2022
    Publication date: April 25, 2024
    Inventors: Ao LI, Yile CHEN, Guoqing CAO
  • Patent number: 11620321
    Abstract: An artificial intelligence based method and apparatus for processing information. A specific embodiment of the method includes: acquiring a search record set within a preset time period; matching the search record set with an encyclopedia entry set, and selecting a first set of points of interest from the encyclopedia entry set according to a match result; matching the search record set with a microblog topic set, and selecting a second set of points of interest from the microblog topic set according to a match result; and adding the first set of points of interest and the second set of points of interest to a set of points of interest. This embodiment achieves an accurate acquisition of the points of interest, thus facilitating the implementation of a targeted information push.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: April 4, 2023
    Assignee: Beijing Baidu Netcom Science and Technology Co., Ltd.
    Inventors: Yile Chen, Jianfeng Chi, Jinwen Luo, Weidong Guo, Yajuan Lv
  • Publication number: 20230099739
    Abstract: The present invention provides a JAK kinase inhibitor and a preparation and application thereof, and the present invention specifically provides a compound having a structure represented in the following formula I, an enantiomer thereof, or a pharmaceutically acceptable salt thereof. The compound has uniquely advantageous JAK kinase inhibitory activity, and as such may be used for treatment of a disease or illness related to JAK kinase activity or expression level.
    Type: Application
    Filed: March 10, 2021
    Publication date: March 30, 2023
    Inventors: Ao LI, Prabhakar Kondaji JADHAV, Yuanshan YAO, Yile CHEN, Guoqing CAO
  • Patent number: 11551045
    Abstract: An artificial intelligence based method and apparatus for processing information. A specific embodiment of the method includes: acquiring search click information recorded within a predetermined time period; generating a candidate entry set by selecting, from the search click information, entries having click volumes exceeding a click volume threshold within a preset unit time period; forming, for each candidate entry in the candidate entry set, a click volume sequence according to a chronological order of each of the click volumes corresponding to the candidate entry in the predetermined time period; determining, based on click volume sequences, categories of the candidate entries respectively corresponding to click volume sequences; and determining candidate entries having the categories being a preset category as points of interest to generate a set of points of interest.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: January 10, 2023
    Assignee: Beijing Baidu Netcom Science and Technology Co., Ltd.
    Inventors: Jinwen Luo, Weidong Guo, Yile Chen, Jianfeng Chi, Yajuan Lv
  • Patent number: 11498922
    Abstract: The present invention relates to methods of making certain pyrrolopyrimidine derivatives, which are useful in the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3(D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways, salts, polymorphs, and amorphous forms of said compounds, synthetic intermediates for preparing said compounds, and pharmaceutical compositions comprising said compounds and methods for making such compositions.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: November 15, 2022
    Assignees: ACEA Therapeutics, Inc., Hangzhou ACEA Pharmaceutical Research Co., Ltd., Zhejiang ACEA Pharmaceuticals Co., Ltd.
    Inventors: Long Mao, Jia Liu, Yile Chen, Yuning Hua, Kongen Dai, Yimei Bao, Bojie Weng, Xi-aopeng Mo, Jian Wu, Xiao Xu, Wanhong Xu, Xiaobo Wang
  • Publication number: 20210309642
    Abstract: The invention relates to solid forms of certain N-(pyrimidinyloxy)acrylamide derivatives that are useful in the treatment of proliferation and immunological disorders and other diseases related to the dysregulation of kinases including EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3 (D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK. The invention provides methods of making these materials and their salts and polymorphs, and intermediates for preparing these materials, as well as pharmaceutical compositions comprising these materials. The solid forms and pharmaceutical compositions comprising them are useful to treat conditions including a proliferation disorder, a tumor, an inflammatory disease, an autoimmune disease, psoriasis, dry eye, rheumatoid arthritis, or lupus.
    Type: Application
    Filed: August 9, 2018
    Publication date: October 7, 2021
    Applicants: ACEA Therapeutics, Inc., HANGZHOU ACEA PHARMACEUTICAL RESEARCH CO., LTD., ZHEJIANG ACEA PHARMACEUTICALS CO., LTD.
    Inventors: Long MAO, Jia LIU, Yile CHEN, Yuning HUA, Kunhua DONG, Liang CHEN, Bojie WENG, Xiaopeng MO, Kongen DAI, Yimei BAO, Jian WU, Bin LIANG, Guanglin ZHOU, Zhen WANG
  • Publication number: 20210300931
    Abstract: Disclosed methods of making certain pyrrolopyrimidine derivatives, which are useful in the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3(D835Y), ITK, JAK1, JAK2, JAK3, TEC AND TXK) and/or the respective pathways, salts, polymorphs, and amorphous forms of said compounds, synthetic intermediates for preparing said compounds, and pharmaceutical compositions comprising said compounds and methods for making such compositions.
    Type: Application
    Filed: April 7, 2017
    Publication date: September 30, 2021
    Applicants: ACEA Therapeutics, Inc., Hangzhou ACEA Pharmaceutical Research Co., Ltd., Zhejiang ACEA Pharmaceuticals Co., Ltd.
    Inventors: Long MAO, Jia LIU, Yile CHEN, Yuning HUA, Kongen DAI, Yimei BAO, Bojie WENG, Xi-aopeng MO, Jian WU, Xiao XU, Wanhong XU, Xiaobo WANG
  • Patent number: 11023505
    Abstract: A method and apparatus for pushing information. A specific implementation of the method includes: parsing page content browsed by a user to extract a keyword of the page content and determine a theme corresponding to the keyword; determining a preset keyword matching the keyword in a preset keyword collection; determining an associated keyword associated with the determined preset keyword based on a pre-established associated relationship of the preset keyword; and pushing information corresponding to the theme and/or the associated keyword to the user. This implementation implements targeted information push.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: June 1, 2021
    Assignee: Beijing Baidu Netcom Science and Technology Co., Ltd.
    Inventors: Jianfeng Chi, Weidong Guo, Yajuan Lv, Yile Chen, Jinwen Luo
  • Patent number: 10533011
    Abstract: Provided are methods of making certain pyrrolopyrimidine derivatives, which are useful in the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3 (D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways, salts, polymorphs, and amorphous forms of said compounds, synthetic intermediates for preparing said compounds, and pharmaceutical compositions comprising said compounds and methods for making such compositions.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: January 14, 2020
    Assignee: ACEA THERAPEUTICS, INC.
    Inventors: Long Mao, Jia Liu, Yile Chen, Yuning Hua, Kongen Dai, Yimei Bao, Bojie Weng, Xiaopeng Mo, Jian Wu, Xiao Xu, Wanhong Xu, Xiaobo Wang
  • Publication number: 20190005126
    Abstract: The present disclosure discloses an artificial intelligence based method and apparatus for processing information. A specific embodiment of the method includes: acquiring a search record set within a preset time period; matching the search record set with an encyclopedia entry set, and selecting a first set of points of interest from the encyclopedia entry set according to a match result; matching the search record set with a microblog topic set, and selecting a second set of points of interest from the microblog topic set according to a match result; and adding the first set of points of interest and the second set of points of interest to a set of points of interest. This embodiment achieves an accurate acquisition of the points of interest, thus facilitating the implementation of a targeted information push.
    Type: Application
    Filed: March 23, 2018
    Publication date: January 3, 2019
    Inventors: Yile Chen, Jianfeng Chi, Jinwen Luo, Weidong Guo, Yajuan Lv
  • Publication number: 20190005121
    Abstract: A method and apparatus for pushing information. A specific implementation of the method includes: parsing page content browsed by a user to extract a keyword of the page content and determine a theme corresponding to the keyword; determining a preset keyword matching the keyword in a preset keyword collection; determining an associated keyword associated with the determined preset keyword based on a pre-established associated relationship of the preset keyword; and pushing information corresponding to the theme and/or the associated keyword to the user. This implementation implements targeted information push.
    Type: Application
    Filed: March 20, 2018
    Publication date: January 3, 2019
    Inventors: Jianfeng Chi, Weidong Guo, Yajuan Lv, Yile Chen, Jinwen Luo
  • Publication number: 20180365534
    Abstract: The present disclosure discloses an artificial intelligence based method and apparatus for processing information. A specific embodiment of the method includes: acquiring search click information recorded within a predetermined time period; generating a candidate entry set by selecting, from the search click information, entries having click volumes exceeding a click volume threshold within a preset unit time period; forming, for each candidate entry in the candidate entry set, a click volume sequence according to a chronological order of each of the click volumes corresponding to the candidate entry in the predetermined time period; determining, based on click volume sequences, categories of the candidate entries respectively corresponding to click volume sequences; and determining candidate entries having the categories being a preset category as points of interest to generate a set of points of interest.
    Type: Application
    Filed: March 23, 2018
    Publication date: December 20, 2018
    Inventors: Jinwen Luo, Weidong Guo, Yile Chen, Jianfeng Chi, Yajuan Lv
  • Publication number: 20180312510
    Abstract: Provided are methods of making certain pyrrolopyrimidine derivatives, which are useful in the treatment of proliferation disorders and other diseases related to the dysregulation of kinase (such as, but not limited to, EGFR (including HER), Alk, PDGFR, BLK, BMX/ETK, BTK, FLT3 (D835Y), ITK, JAK1, JAK2, JAK3, TEC and TXK) and/or the respective pathways, salts, polymorphs, and amorphous forms of said compounds, synthetic intermediates for preparing said compounds, and pharmaceutical compositions comprising said compounds and methods for making such compositions.
    Type: Application
    Filed: June 30, 2016
    Publication date: November 1, 2018
    Applicant: ACEA THERAPEUTICS, INC.
    Inventors: Long MAO, Jia LIU, Yile CHEN, Yuning HUA, Kongen DAI, Yimei BAO, Bojie WENG, Xiaopeng MO, Jian WU, Xiao XU, Wanhong XU, Xiaobo WANG